S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
This MMJ Stock Needs To Be At The Top Of Your Radar! (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
This MMJ Stock Needs To Be At The Top Of Your Radar! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Central Bank: “Final stage” beginning now (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
This MMJ Stock Needs To Be At The Top Of Your Radar! (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
This MMJ Stock Needs To Be At The Top Of Your Radar! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Central Bank: “Final stage” beginning now (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
This MMJ Stock Needs To Be At The Top Of Your Radar! (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
This MMJ Stock Needs To Be At The Top Of Your Radar! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Central Bank: “Final stage” beginning now (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
This MMJ Stock Needs To Be At The Top Of Your Radar! (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
This MMJ Stock Needs To Be At The Top Of Your Radar! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Central Bank: “Final stage” beginning now (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain

Cannabis Stocks List

Compare cannabis stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Learn more about trading Cannabis/Marijuana stocks.

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aphria Inc. stock logo
APHA
Aphria
$15.38
$15.48
$2.78
$32.29
$4.87 B2.6721.83 million shsN/A
Canopy Growth Co. stock logo
CGC
Canopy Growth
$1.09
+3.8%
$1.51
$1.02
$5.95
$562.44 M2.097.45 million shs14.84 million shs
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
$218.96
$218.59
$87.07
$219.57
$6.86 B2.15899,771 shsN/A
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
$134.27
+1.9%
$140.33
$125.36
$163.31
$8.59 B0.75495,679 shs703,600 shs
Tilray Inc stock logo
TLRY
Tilray
$2.41
-1.2%
$2.48
$2.17
$5.12
$1.49 B2.6610.64 million shs6.56 million shs
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$0.67
+6.0%
$0.65
$0.55
$3.10
$234.85 M2.575.03 million shs4.91 million shs
HEXO Corp. stock logo
HEXO
HEXO
$1.42
+1.4%
$1.31
$0.90
$4.30
$62.48 M1.35983,272 shs403,500 shs
Altria Group, Inc. stock logo
MO
Altria Group
$45.30
+0.5%
$45.65
$40.35
$54.89
$80.86 B0.597.95 million shs6.56 million shs
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
$69.04
-1.1%
$70.44
$39.06
$102.25
$3.87 B1.63778,617 shs552,100 shs
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
$2.83
-1.8%
$2.74
$2.19
$7.90
$1.77 BN/A617,590 shs321,400 shs

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aphria Inc. stock logo
APHA
Aphria
0.00%0.00%0.00%0.00%0.00%
Canopy Growth Co. stock logo
CGC
Canopy Growth
0.00%+3.81%-18.66%-56.57%-80.25%
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
0.00%-1.07%-7.62%-9.11%-9.60%
Tilray Inc stock logo
TLRY
Tilray
0.00%0.00%+4.78%-19.93%-48.94%
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.00%+19.27%+8.16%-28.64%-77.20%
HEXO Corp. stock logo
HEXO
HEXO
0.00%+4.41%+20.34%-14.97%-63.85%
Altria Group, Inc. stock logo
MO
Altria Group
0.00%-0.81%-1.84%-5.76%-11.33%
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
0.00%+4.62%-2.50%-19.68%-24.14%
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
0.00%+14.70%+21.87%-27.51%-54.84%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aphria Inc. stock logo
APHA
Aphria
N/AN/AN/AN/AN/AN/AN/AN/A
Canopy Growth Co. stock logo
CGC
Canopy Growth
1.657 of 5 stars
3.02.00.00.03.20.01.3
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
2.6285 of 5 stars
3.42.00.04.02.52.52.5
Tilray Inc stock logo
TLRY
Tilray
1.5907 of 5 stars
2.91.00.00.02.00.01.3
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1.5382 of 5 stars
3.10.00.00.00.60.01.3
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/AN/AN/AN/A
Altria Group, Inc. stock logo
MO
Altria Group
1.712 of 5 stars
1.03.04.20.02.40.81.9
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
2.4023 of 5 stars
2.42.02.51.53.04.21.9
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
2.0255 of 5 stars
3.45.00.00.01.70.00.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aphria Inc. stock logo
APHA
Aphria
0.00
N/AN/AN/A
Canopy Growth Co. stock logo
CGC
Canopy Growth
1.93
Hold$4.39302.67% Upside
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
0.00
N/AN/AN/A
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
2.88
Moderate Buy$200.7549.51% Upside
Tilray Inc stock logo
TLRY
Tilray
1.89
Hold$4.7496.75% Upside
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
2.17
Hold$1.40109.61% Upside
HEXO Corp. stock logo
HEXO
HEXO
1.83
HoldN/AN/A
Altria Group, Inc. stock logo
MO
Altria Group
2.00
Hold$44.67-1.40% Downside
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
2.71
Moderate Buy$76.2910.49% Upside
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
2.88
Moderate Buy$10.00253.69% Upside

Current Analyst Ratings

Latest Cannabis Stocks Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2023
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
5/11/2023
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$207.00 ➝ $202.00
5/11/2023
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$205.00 ➝ $212.00
5/8/2023
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$80.00
5/5/2023
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$80.00 ➝ $70.00
5/4/2023
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$80.00 ➝ $78.00
5/4/2023
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$70.00 ➝ $65.00
5/4/2023
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$92.00 ➝ $86.00
5/4/2023
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$100.00 ➝ $85.00
5/2/2023
Canopy Growth Co. stock logo
CGC
Canopy Growth
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$2.00 ➝ $1.00
5/1/2023
Canopy Growth Co. stock logo
CGC
Canopy Growth
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Market Perform
(Data available from 5/21/2020 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aphria Inc. stock logo
APHA
Aphria
$405.96M12.00$0.09 per share166.43$4.80 per share3.20
Canopy Growth Co. stock logo
CGC
Canopy Growth
$415.09M1.35$0.67 per share1.63$7.27 per share0.15
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
$311.33M22.05$0.01 per share18,588.22$23.48 per share9.33
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
$3.66B2.35$22.49 per share5.97$52.11 per share2.58
Tilray Inc stock logo
TLRY
Tilray
$628.37M2.37N/AN/A$8.34 per share0.29
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$174.88M1.34N/AN/A$2.31 per share0.29
HEXO Corp. stock logo
HEXO
HEXO
$146.20M0.43N/AN/A$5.76 per share0.25
Altria Group, Inc. stock logo
MO
Altria Group
$25.10B3.22$5.03 per share9.01($2.14) per share-21.17
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
$3.92B0.99$5.98 per share11.54$2.45 per share28.18
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
$1.34B1.32N/AN/A$2.07 per share1.37

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aphria Inc. stock logo
APHA
Aphria
-$63.21M-$0.06N/A219.71N/A-36.10%-2.30%-1.66%N/A
Canopy Growth Co. stock logo
CGC
Canopy Growth
-$241.08M-$6.01N/AN/AN/A-721.40%-46.02%-24.62%5/26/2023 (Estimated)
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
-$9.02M-$0.24N/A608.22N/A-11.05%-7.46%-6.13%N/A
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
-$224.06M-$2.54N/A7.980.75-4.18%24.72%7.03%8/2/2023 (Estimated)
Tilray Inc stock logo
TLRY
Tilray
-$476.80M-$3.04N/AN/AN/A-294.54%-6.51%-5.26%7/27/2023 (Estimated)
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$1.36B-$6.04N/AN/AN/A-817.07%-62.73%-38.13%5/25/2023 (Estimated)
HEXO Corp. stock logo
HEXO
HEXO
-$845.90M-$7.05N/AN/AN/A-217.60%-64.50%-29.01%6/13/2023 (Estimated)
Altria Group, Inc. stock logo
MO
Altria Group
$5.76B$3.1114.578.532.2322.44%-245.43%24.43%7/27/2023 (Estimated)
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
-$437.50M-$11.21N/A17.17N/A-16.57%81.02%3.29%8/2/2023 (Estimated)
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
-$370.10M-$0.54N/AN/AN/A-28.88%-19.76%-8.17%N/A

Latest Cannabis Stocks Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/22/2023N/A
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/A-$0.05-$0.05N/AN/AN/A
5/17/2023Q1 2023
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
-$0.05-$0.05N/A-$0.03$332.21 million$336.50 million  
5/3/2023Q2 2023
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
$3.20$3.78+$0.58$5.62$1.61 billion$1.53 billion    
4/27/2023Q1 2023
Altria Group, Inc. stock logo
MO
Altria Group
$1.19$1.18-$0.01$1.36$4.89 billion$4.76 billion      
4/10/20232/28/2023
Tilray Inc stock logo
TLRY
Tilray
-$0.06-$1.90-$1.84$1.82$150.13 million$145.59 million    
3/1/2023Q4 2022
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
N/A-$0.84-$0.84$2.14$972.70 million$972.12 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aphria Inc. stock logo
APHA
Aphria
N/AN/AN/AN/AN/A
Canopy Growth Co. stock logo
CGC
Canopy Growth
N/AN/AN/AN/AN/A
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
N/AN/AN/AN/AN/A
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
N/AN/AN/AN/AN/A
Tilray Inc stock logo
TLRY
Tilray
N/AN/AN/AN/AN/A
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/A
Altria Group, Inc. stock logo
MO
Altria Group
$3.768.30%+3.91%120.90%13 Years
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
$2.643.82%+5.32%N/A N/A
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
N/AN/AN/AN/AN/A

Latest Cannabis Stocks Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/18/2023
Altria Group, Inc. stock logo
MO
Altria Group
Quarterly$0.948.3%6/14/20236/15/20237/10/2023
4/24/2023
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
quarterly$0.663.8%5/25/20235/26/20236/9/2023
3/1/2023
Altria Group, Inc. stock logo
MO
Altria Group
quarterly$0.948.15%3/23/20233/24/20234/28/2023
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aphria Inc. stock logo
APHA
Aphria
0.25
2.36
1.17
Canopy Growth Co. stock logo
CGC
Canopy Growth
0.53
1.73
1.41
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
0.01
5.13
4.31
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
1.71
3.06
2.32
Tilray Inc stock logo
TLRY
Tilray
0.09
1.61
1.18
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.33
4.08
3.16
HEXO Corp. stock logo
HEXO
HEXO
N/A
0.54
0.34
Altria Group, Inc. stock logo
MO
Altria Group
N/A
0.78
0.65
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
22.82
2.07
1.25
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
0.74
1.23
0.72

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Aphria Inc. stock logo
APHA
Aphria
1,200316.80 millionN/AOptionable
Canopy Growth Co. stock logo
CGC
Canopy Growth
3,151516.00 million514.97 millionOptionable
GW Pharmaceuticals plc stock logo
GWPH
GW Pharmaceuticals
1,16131.35 millionN/AOptionable
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
2,80064.00 million61.19 millionOptionable
Tilray Inc stock logo
TLRY
Tilray
1,800618.01 million602.31 millionOptionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,338351.62 million351.59 millionOptionable
HEXO Corp. stock logo
HEXO
HEXO
1,27744.00 million41.93 millionOptionable
Altria Group, Inc. stock logo
MO
Altria Group
6,3001.79 billion1.78 billionOptionable
The Scotts Miracle-Gro Company stock logo
SMG
Scotts Miracle-Gro
6,10056.07 million40.78 millionOptionable
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
5,931624.28 millionN/ANot Optionable

Cannabis Stocks Headlines

SourceHeadline
Benchmark Lowers Curaleaf (OTCMKTS:CURLF) to HoldBenchmark Lowers Curaleaf (OTCMKTS:CURLF) to Hold
americanbankingnews.com - May 22 at 3:59 AM
Q2 2023 EPS Estimates for Curaleaf Holdings, Inc. Reduced by Analyst (OTCMKTS:CURLF)Q2 2023 EPS Estimates for Curaleaf Holdings, Inc. Reduced by Analyst (OTCMKTS:CURLF)
marketbeat.com - May 22 at 1:28 AM
Curaleaf (OTCMKTS:CURLF) Issues  Earnings ResultsCuraleaf (OTCMKTS:CURLF) Issues Earnings Results
americanbankingnews.com - May 19 at 9:14 AM
Curaleaf (OTCMKTS:CURLF) Stock Rating Lowered by BenchmarkCuraleaf (OTCMKTS:CURLF) Stock Rating Lowered by Benchmark
marketbeat.com - May 19 at 8:00 AM
Curaleaf is a Buy in cannabis stocks, says BeaconCuraleaf is a Buy in cannabis stocks, says Beacon
cantechletter.com - May 18 at 11:49 PM
Curaleaf evokes conservative forecasts after 1Q to tie in with Streets expectationsCuraleaf evokes conservative forecasts after 1Q to tie in with Street's expectations
proactiveinvestors.com - May 18 at 2:04 PM
Curaleaf Holdings, Inc.: Curaleaf Reports First Quarter 2023 ResultsCuraleaf Holdings, Inc.: Curaleaf Reports First Quarter 2023 Results
finanznachrichten.de - May 18 at 8:47 AM
Curaleaf Q1 Revenue Falls 2% SequentiallyCuraleaf Q1 Revenue Falls 2% Sequentially
newcannabisventures.com - May 17 at 7:49 PM
Curaleaf Q1 Revenue Grows 14%, Optimizing U.S. Assets & Heading To Europe Says Boss Boris JordanCuraleaf Q1 Revenue Grows 14%, Optimizing U.S. Assets & Heading To Europe Says Boss Boris Jordan
markets.businessinsider.com - May 17 at 7:49 PM
Curaleaf Holdings: Q1 Earnings InsightsCuraleaf Holdings: Q1 Earnings Insights
msn.com - May 17 at 7:49 PM
Curaleaf Reports First Quarter 2023 ResultsCuraleaf Reports First Quarter 2023 Results
finance.yahoo.com - May 17 at 7:49 PM
Curaleaf remains a Buy, according to RothCuraleaf remains a Buy, according to Roth
cantechletter.com - May 17 at 2:48 PM
Preview: Curaleaf Holdingss EarningsPreview: Curaleaf Holdings's Earnings
msn.com - May 16 at 2:22 PM
Curaleaf (CURLF) Scheduled to Post Earnings on WednesdayCuraleaf (CURLF) Scheduled to Post Earnings on Wednesday
americanbankingnews.com - May 16 at 7:46 AM
Analysts Set Curaleaf Holdings, Inc. (OTCMKTS:CURLF) PT at $10.00Analysts Set Curaleaf Holdings, Inc. (OTCMKTS:CURLF) PT at $10.00
americanbankingnews.com - May 16 at 2:32 AM
Cannabis Stocks? Come On In, The Waters Warm: Sundial, TerrAscend & Curaleaf All Had Great MonthCannabis Stocks? Come On In, The Water's Warm: Sundial, TerrAscend & Curaleaf All Had Great Month
msn.com - May 12 at 9:12 PM
Curaleaf stock price analysis: sell in May and go away - InvestorsObserverCuraleaf stock price analysis: sell in May and go away - InvestorsObserver
news.google.com - May 12 at 9:57 AM
Top Cannabis Stocks for May 2023 - InvestopediaTop Cannabis Stocks for May 2023 - Investopedia
news.google.com - May 10 at 5:01 PM
5 Key Takeaways From Curaleaf’s Earnings Report5 Key Takeaways From Curaleaf’s Earnings Report
technical420.com - May 10 at 12:00 PM
Is Curaleaf Stock a Buy Now?Is Curaleaf Stock a Buy Now?
msn.com - May 10 at 12:00 PM
Cannabis Extraction Market 2023 Segments Analysis by Top Key ... - Cottonwood Holladay JournalCannabis Extraction Market 2023 Segments Analysis by Top Key ... - Cottonwood Holladay Journal
news.google.com - May 10 at 7:00 AM
Marijuana shop owner to campaign against unfair dispensary cap ... - Seacoastonline.comMarijuana shop owner to campaign against 'unfair' dispensary cap ... - Seacoastonline.com
news.google.com - May 10 at 7:00 AM
Q1 2023 EPS Estimates for Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Decreased by AnalystQ1 2023 EPS Estimates for Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Decreased by Analyst
americanbankingnews.com - May 10 at 1:38 AM
Is Curaleaf Stock a Buy Now? - NasdaqIs Curaleaf Stock a Buy Now? - Nasdaq
news.google.com - May 9 at 3:42 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Aphria logo

Aphria

NASDAQ:APHA
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
Canopy Growth logo

Canopy Growth

NASDAQ:CGC
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
GW Pharmaceuticals logo

GW Pharmaceuticals

NASDAQ:GWPH
GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in various disease areas. Its lead product is Epidiolex, an oral medicine for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. The company also develops and markets Sativex for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of schizophrenia, autism spectrum disorder, neuropsychiatric symptom, and neonatal hypoxic ischemic encephalopathy. It primarily operates in Europe, the United Kingdom, the United States, and internationally. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.
Jazz Pharmaceuticals logo

Jazz Pharmaceuticals

NASDAQ:JAZZ
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
Tilray logo

Tilray

NASDAQ:TLRY
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.
Aurora Cannabis logo

Aurora Cannabis

NYSE:ACB
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.
HEXO logo

HEXO

NYSE:HEXO
HEXO Corp. engages in the provision of cannabis and cannabis products. The company was founded by Sébastien St. Louis and Adam Miron on October 29, 2013 and is headquartered in Gatineau, Canada.
Altria Group logo

Altria Group

NYSE:MO
Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.
Scotts Miracle-Gro logo

Scotts Miracle-Gro

NYSE:SMG
Scotts Miracle-Gro Co. engages in the manufacturing, marketing, and sale of products for lawn and garden care and indoor and hydroponic gardening. Its products and services include lawn care, gardening and landscape, hydroponic hardware and growing environments, lighting, controls, and marketing agreement. It operates through the following segments: U.S. Consumer, Hawthorne, and Other. The U.S. Consumer and Other segments manufacture and market branded consumer lawn and garden products. The U.S. Consumer segment consists of consumer lawn and garden business in the United States. The Hawthorne segment manufactures, markets, and distributes lighting, nutrients, growing media, growing environments, and hardware products for indoor and hydroponic gardening in North America. The company was founded by Orlando McLean Scott in 1868 and is headquartered in Marysville, OH.
Curaleaf logo

Curaleaf

OTCMKTS:CURLF
Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

Key Points

  • The size and scope of the cannabis industry can take your breath away — it's not just about farmers growing marijuana plants or your local dispensary. 
  • Growers, dispensaries and pharmaceutical companies provide the infrastructure for the industry. 
  • Learn the steps ensure you understand the opportunities in cannabis investment. 

Learning how to invest in cannabis is not for risk-averse investors. If you were investing in cannabis in 2017 and 2018, you know how far and how fast these stocks can rise and fall. 

Still, the potential for this industry remains tantalizing. Before you invest your hard-earned capital in this sector, you need to understand the different types of cannabis investments, the risks of investing in cannabis and the eight steps you can take to invest in cannabis. 

Basics of the Cannabis Industry

The size and scope of the cannabis industry can take your breath away — it's not just about farmers growing marijuana plants or your local dispensary. 

The cannabis industry ties in growers, dispensaries, pharmaceutical companies and companies that help provide the infrastructure. It's a complex industry of intertwined interests and made even more complicated because cannabis remains a banned substance by the federal government. 

That hasn't stopped individual states from taking up the question of cannabis regulation, but that creates another obstacle. There is no uniform status regarding the legal status of cannabis. 

The good news if you're interested in cannabis investing is that as of January 2023, only six states (North Carolina, South Carolina, Nebraska, Kansas, Idaho and Wyoming) have not legalized cannabis at any level. You may be equally surprised to find that 22 states have made cannabis fully legal, meaning you can use it for recreational and medicinal purposes. 

Now, the bad news. Investors looking to invest in weed face an uphill climb. Even in states where cannabis is no longer decriminalized, some restrictions are tied to how much individuals can possess and grow. The remaining 23 states have varying legal standards that make cannabis regulation a crazy quilt for cannabis companies to navigate, as the chart below shows. 

how to invest in cannabis

Status of Cannabis Legalization by State

This chart provides a broad overview of the status of cannabis legalization in the United States. There are nuances in many states that you can research by state

Fully Legal (Recreational and Medical Use

Legal for Medical Use Only

Legal for CBD Oil Only 

Not Legal

Alaska

Arkansas

Alabama (non-psychoactive)

Idaho

Arizona

Delaware

Georgia

Kansas

California

Florida

Indiana

Nebraska**

Colorado

Oklahoma

Iowa

North Carolina***

Connecticut

Pennsylvania

Kentucky

South Carolina

District of Columbia

South Dakota

Tennessee

Wyoming

Hawaii*

Utah

Texas

 

Illinois

West Virginia

Wisconsin

 

Louisiana*

     

Maine

     

Maryland

     

Massachusetts

     

Michigan

     

Minnesota*

     

Mississippi*

     

Missouri

     

Montana

     

New Hampshire*

     

New Mexico

     

New Jersey

     

New York

     

Nevada

     

North Dakota*

     

Ohio*

     

Oregon

     

Rhode Island

     

Vermont

     

Virginia

     

Washington

     

*Although technically considered not fully legal, these states have passed laws that allow for the use of cannabis for medical and recreational purposes with heavy restrictions.

**Although officially illegal, Nebraska has passed laws decriminalizing small amounts of marijuana.

***North Carolina allows CBD oil for patients with treatment-resistant epilepsy.

Overview of Cannabis Stocks

If you're considering investing in cannabis stocks, the chart above shows both the short-term risk and the long-term opportunity. Taking advantage of this opportunity starts by considering what kind of cannabis stocks you want to buy. 

But first, a word of caution. Cannabis investments are inherently risky. Many of these companies are small-cap companies (meaning they have a market cap of less than $2 billion). 

The risk is that small-cap stocks frequently have less liquidity than their large-cap counterparts. That means sending the prices moving in either direction doesn't take much. And when the stock price makes a sharp move, you can lose a lot of money if you're on the wrong side of the trade. 

The other risk comes from the financial situation of many cannabis companies. Even when the cannabis bubble blew up in 2018 and early 2019, many companies were not profitable. Many of these stocks are trading as penny stocks, meaning they trade for $5 or less. Be sure to learn about penny stocks before investing.

The takeaway is that investing in cannabis in 2023 is not like choosing from a list of FAANG stocks. And it's nothing like blue-chip investing. This sector is only for risk-tolerant investors. With that in mind, let's look at the type of cannabis investments.

Types of Cannabis Investments

As mentioned earlier, several types of companies make up the cannabis industry. This list includes growers, retailers (dispensaries), pharmaceutical companies and companies that help provide the infrastructure for the cannabis industry. Here's a brief overview of each type of cannabis investment.

Growers

Also known as cultivation, this is the sector where companies breed and produce a variety of cannabis strains. These companies employ individuals who have extensively worked in botany and plant science. This area covers areas like hydroponics, vertical farming and automation in the cannabis industry. 

Investing in growers was popular in 2017 and 2018 for a good reason. Investors believed that the companies with the largest supply would be the winners. But as the industry failed to launch as expected, many of these companies became oversupplied. However, if and when the cannabis industry begins to fire on all cylinders, this supply-demand dynamic should change, and these stocks will be the first to move higher. 

Retailers

Retailers are the customer-facing side of the marijuana business. In many cases, a staff has to be familiar with the effects of different marijuana strains and the effect of varying consumption methods. In the case of medical marijuana, staff members may even have pharmacy training.

At this time, many of these businesses are not publicly traded. However, this is an area to watch, as consolidation will likely occur as many growers try to control the entire purchase cycle.  

Manufacturers

Manufacturers include companies in a field known as cannatech. These are tech companies that are bringing their expertise to the cannabis industry. Currently, they help producers with a digital presence by supplying innovative services and solutions that improve the product and customer experience while at the same time complying with federal and state regulations. 

This area also includes companies that help provide the infrastructure for cannabis companies, such as greenhouses. Investing in this sector may include investing in real estate investment trusts (REITs) that own cannabis-related properties.  

Drugmakers

The first thing many investors may consider in this section is CBD oil, one of the first genuinely mainstream products. More effort will go into discovering ways to make cannabis more accessible for medicinal purposes.

"How to invest in CBD oil stocks?" is a different question. Many of these companies are private companies and are likely to stay that way as long as cannabis continues to be a banned substance at the federal level.  

8 Steps for Investing in Cannabis

So, how to invest in marijuana? First, let's consider the opportunity. According to Grand View Market Research, the value of the worldwide legal cannabis market may reach $91.5 billion by 2028. That would mean a compound annual growth rate (CAGR) of 26.3%. 

But like investing in any segment, investing in cannabis requires due diligence. Here are some steps to follow to ensure you understand the opportunities in cannabis investment. 

Step 1: Know what you’re investing in. 

The medical marijuana market is further ahead of the recreational market in terms of being legal in all 50 states. Still, as the chart shows, all states have different regulations.  

Step 2: Decide on what type of cannabis company you want to invest in.

As we listed earlier, there are opportunities to invest in various stages of the cannabis process. 

Step 3: Perform fundamental analysis.

In addition to universal stock research, like looking at a company's management team, understanding its marketing plan and reviewing financial statements, you'll have to become familiar with some specific metrics for the cannabis industry: 

  • All-in cost of sales per gram: A company's total per-gram cost of producing cannabis.
  • Cash cost per gram: A company's total per-gram cost of producing cannabis, excluding the costs associated with amortization, packaging and inventory adjustments.

Step 4: Choose individual stocks or ETFs.

As you might expect, there are a variety of exchange-traded funds (ETFs) that invest in the cannabis industry. These can allow less risk-tolerant investors to gain exposure to this sector.  

Step 5: Invest your money.

For most investors, it's best to build a position slowly when investing in the cannabis industry, which means picking one or two stocks or a single fund to start. You can use simple dollar-cost averaging to increase your position over time.

Step 6: Continually monitor industry events.

Like any other company you invest in, you have to set aside time to keep track of the stocks you own. MarketBeat makes this easy by sending real-time alerts for stocks in your portfolio or watchlist.  

Step 7: Understand the risks.

The cannabis sector has many risks (see below). Some are unique to this industry and others are similar to what you expect from any penny stock.  

Step 8: Let MarketBeat help.

If you haven't done so already, subscribe to MarketBeat All Access to give you immediate free access to our premium reports, such investing in marijuana stocks for beginners. MarketBeat can also be your go-to research for guidance on how to invest in the tech sector

Risks of Investing in Cannabis

There are several risks for those who are investing in marijuana. First, without full legalization at the federal level, it's difficult, if not impossible, for businesses to operate across state borders. That means cannabis companies have to be licensed in several states (known as multistate operators). These companies are having some success, and they are multiplying. But you'll have to invest in more than one of these companies if you want full coverage of the cannabis market.

The second issue has to do with banking. Because marijuana is not legal in every state, many marijuana-related businesses (MRBs) have difficulty accessing traditional banking products. As of September 30, 2019, the Financial Crimes Enforcement Network (FinCEN) reported that 563 banks and 160 credit unions provided banking services to MRBs. 

This number is growing but still represents only a small fraction of the industry. The report doesn't give insight into what financial products these companies were able to access. 

And even for publicly traded stocks, concerns about supply and demand imbalances will continue to plague the industry. Another risk is that many of these stocks trade as over-the-counter (OTC) stocks, which means they may have different liquidity than other publicly traded stocks. These companies are also subject to different levels of accountability regarding providing shareholders with financial information. 

Finally, as investors saw in 2018, many of these companies still operate without much cash on their balance sheet, which can lead to the companies having to take actions that can dilute shareholder value. 

Future of Investing in Cannabis

The cannabis sector has tremendous potential. But it's also got plenty of risk. If you're considering investing in this space, you have to be comfortable with investing in an opaque industry that will face high regulation in the future. 

Is Investing in Cannabis Stocks Right for You?

The legalization of cannabis at the federal level still feels like a question of "when," not "if." With virtually every state legalizing cannabis for medicinal purposes, at the very least, pressure will likely come to bear on Congress at some point.

My Account -